开云app官网登录入口网页版-官方正版

#HBsAg#

29篇内容 | 2212人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2225075, encodeId=7af622250e57a, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a> <a href='/topic/show?id=018880e834b' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α-2b#</a>, objectTitle=【期刊导读】慢性HBV感染女性产后采用基于聚乙二醇干扰素α-2b治疗48周的HBsAg清除率达50%, objectType=article, longId=842010, objectId=66c18420107c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240706/1720278845035_5579292.jpg, objectUrl=/article/show_article.do?id=66c18420107c, replyNumber=0, likeNumber=7, createdTime=2024-09-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=66c18420107c, moduleTitle=【期刊导读】慢性HBV感染女性产后采用基于聚乙二醇干扰素α-2b治疗48周的HBsAg清除率达50%, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=66c18420107c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2225073, encodeId=0e3922250e377, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2024】合并脂肪肝的HBeAg阴性不确定期慢乙肝患者采用间歇治疗策略获HBsAg血清学转换, objectType=article, longId=841868, objectId=e85284186840, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=e85284186840, replyNumber=0, likeNumber=12, createdTime=2024-09-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e85284186840, moduleTitle=【愈见乙肝2024】合并脂肪肝的HBeAg阴性不确定期慢乙肝患者采用间歇治疗策略获HBsAg血清学转换, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e85284186840)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2224216, encodeId=546d222421682, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】系统综述与网状荟萃分析：聚乙二醇干扰素α停药后的HBsAg清除率随观察时间递增, objectType=article, longId=841094, objectId=2acd8410948c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719201193789_92910.png, objectUrl=/article/show_article.do?id=2acd8410948c, replyNumber=0, likeNumber=22, createdTime=2024-09-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2acd8410948c, moduleTitle=【期刊导读】系统综述与网状荟萃分析：聚乙二醇干扰素α停药后的HBsAg清除率随观察时间递增, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2acd8410948c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2223435, encodeId=395d222343517, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2024】长期核苷治疗的HBeAg阳性慢乙肝患者通过个体化间歇治疗策略获HBsAg血清学转换, objectType=article, longId=840942, objectId=4d2b8409420b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240706/1720278845035_5579292.jpg, objectUrl=/article/show_article.do?id=4d2b8409420b, replyNumber=0, likeNumber=29, createdTime=2024-09-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4d2b8409420b, moduleTitle=【愈见乙肝2024】长期核苷治疗的HBeAg阳性慢乙肝患者通过个体化间歇治疗策略获HBsAg血清学转换, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4d2b8409420b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2223124, encodeId=22122223124a9, content=<a href='/topic/show?id=735a81364b7' target=_blank style='color:#2F92EE;'>#肝细胞癌#</a> <a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=庄辉院士权威解读：慢性乙肝患者HBsAg清除后，HCC监测关键要点, objectType=article, longId=841065, objectId=b64084106599, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719201193789_92910.png, objectUrl=/article/show_article.do?id=b64084106599, replyNumber=0, likeNumber=38, createdTime=2024-08-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b64084106599, moduleTitle=庄辉院士权威解读：慢性乙肝患者HBsAg清除后，HCC监测关键要点, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b64084106599)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2222832, encodeId=2f9e22228321f, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=a7f5118451f6' target=_blank style='color:#2F92EE;'>#APASL 2024#</a> <a href='/topic/show?id=133411845256' target=_blank style='color:#2F92EE;'>#sPD-L1水平#</a>, objectTitle=【期刊导读】HBsAg清除预测新指标：sPD-L1水平, objectType=article, longId=840321, objectId=6b1c84032139, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240723/1721699880262_92910.jpg, objectUrl=/article/show_article.do?id=6b1c84032139, replyNumber=0, likeNumber=33, createdTime=2024-08-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6b1c84032139, moduleTitle=【期刊导读】HBsAg清除预测新指标：sPD-L1水平, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6b1c84032139)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2221714, encodeId=87302221e14d1, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=87e79848366' target=_blank style='color:#2F92EE;'>#隐匿性HBV感染#</a>, objectTitle=【期刊导读】HBV S区突变导致的HBsAg检测不到可能形成隐匿性HBV感染, objectType=article, longId=839402, objectId=a8de83940258, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719201193789_92910.png, objectUrl=/article/show_article.do?id=a8de83940258, replyNumber=0, likeNumber=65, createdTime=2024-08-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a8de83940258, moduleTitle=【期刊导读】HBV S区突变导致的HBsAg检测不到可能形成隐匿性HBV感染, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a8de83940258)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2215446, encodeId=ce99221544675, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=【期刊导读】HBsAg高水平的HBV相关肝癌患者术后无复发生存期更短, objectType=article, longId=835003, objectId=8741835003ff, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240521/1716259408769_5579292.jpg, objectUrl=/article/show_article.do?id=8741835003ff, replyNumber=0, likeNumber=83, createdTime=2024-07-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8741835003ff, moduleTitle=【期刊导读】HBsAg高水平的HBV相关肝癌患者术后无复发生存期更短, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8741835003ff)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2214927, encodeId=0b3e221492e50, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【临床治愈集结号】HBsAg高水平的HBeAg阳性慢乙肝母女经基于聚乙二醇干扰素α的治疗同获HBsAg血清学转换, objectType=article, longId=834591, objectId=9480834591b1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719545882221_8538692.jpg, objectUrl=/article/show_article.do?id=9480834591b1, replyNumber=0, likeNumber=60, createdTime=2024-07-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=9480834591b1, moduleTitle=【临床治愈集结号】HBsAg高水平的HBeAg阳性慢乙肝母女经基于聚乙二醇干扰素α的治疗同获HBsAg血清学转换, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9480834591b1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2214408, encodeId=22ab2214408d3, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=b97885350d' target=_blank style='color:#2F92EE;'>#HBV感染#</a>, objectTitle=【数据阅独】横断面调查：我国肝癌筛查目标人群的HBsAg阳性率为5.23%, objectType=article, longId=830430, objectId=e08f8304309d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720664616921_5579292.png, objectUrl=/article/show_article.do?id=e08f8304309d, replyNumber=0, likeNumber=82, createdTime=2024-07-11, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e08f8304309d, moduleTitle=【数据阅独】横断面调查：我国肝癌筛查目标人群的HBsAg阳性率为5.23%, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e08f8304309d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2213631, encodeId=1f2a2213631c2, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=19332343e64' target=_blank style='color:#2F92EE;'>#乙肝疫苗#</a> <a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a>, objectTitle=【期刊导读】经聚乙二醇干扰素α治疗获得HBsAg清除后联合乙肝疫苗可增强免疫应答，提高HBsAg血清学转换率, objectType=article, longId=829998, objectId=727b8299981e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240705/1720155008578_5579292.jpg, objectUrl=/article/show_article.do?id=727b8299981e, replyNumber=0, likeNumber=66, createdTime=2024-07-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=727b8299981e, moduleTitle=【期刊导读】经聚乙二醇干扰素α治疗获得HBsAg清除后联合乙肝疫苗可增强免疫应答，提高HBsAg血清学转换率, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=727b8299981e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2208673, encodeId=2c3322086e354, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【EASL2024速递】通过抗病毒治疗获得HBsAg清除的慢乙肝患者肝癌发生风险或更低, objectType=article, longId=827509, objectId=8f7a82e509e6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240605/1717574376744_5579292.png, objectUrl=/article/show_article.do?id=8f7a82e509e6, replyNumber=0, likeNumber=101, createdTime=2024-06-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8f7a82e509e6, moduleTitle=【EASL2024速递】通过抗病毒治疗获得HBsAg清除的慢乙肝患者肝癌发生风险或更低, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8f7a82e509e6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2207402, encodeId=a22d220e4025d, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=fcf448e1803' target=_blank style='color:#2F92EE;'>#干扰素α#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【EASL2024速递】聚血糖干扰素α能显著提高核苷停药慢乙肝患者HBsAg清除率, objectType=article, longId=827033, objectId=d5ce82e0333f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240530/1717036023286_5579292.png, objectUrl=/article/show_article.do?id=d5ce82e0333f, replyNumber=0, likeNumber=76, createdTime=2024-05-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d5ce82e0333f, moduleTitle=【EASL2024速递】聚血糖干扰素α能显著提高核苷停药慢乙肝患者HBsAg清除率, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d5ce82e0333f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2201791, encodeId=fc782201e9143, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a> <a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2023】一对HBV DNA、HBsAg和HBeAg高水平的母女经个体化抗病毒治疗均获长期持久的临床治愈, objectType=article, longId=824075, objectId=96f58240e5c9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/health-insurance-PK235DP.jpg, objectUrl=/article/show_article.do?id=96f58240e5c9, replyNumber=0, likeNumber=96, createdTime=2024-05-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=96f58240e5c9, moduleTitle=【愈见乙肝2023】一对HBV DNA、HBsAg和HBeAg高水平的母女经个体化抗病毒治疗均获长期持久的临床治愈, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=96f58240e5c9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2201035, encodeId=616a2201035a6, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】吴超教授团队：预测慢乙肝患者HBsAg血清学转换的新指标——基线HBsAb特异性B细胞, objectType=article, longId=823242, objectId=80158232420f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/health-insurance-PK235DP.jpg, objectUrl=/article/show_article.do?id=80158232420f, replyNumber=0, likeNumber=76, createdTime=2024-04-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=80158232420f, moduleTitle=【期刊导读】吴超教授团队：预测慢乙肝患者HBsAg血清学转换的新指标——基线HBsAb特异性B细胞, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=80158232420f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2200404, encodeId=9cba2200404a8, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=5fcb113801f8' target=_blank style='color:#2F92EE;'>#HBsAb#</a>, objectTitle=【期刊导读】HBsAg和HBsAb双阳性的慢乙肝患儿更易实现临床治愈, objectType=article, longId=822489, objectId=19b2822489a0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/black-surgeon-giving-instruction-to-medical-team-TMPFGNZ.jpg, objectUrl=/article/show_article.do?id=19b2822489a0, replyNumber=0, likeNumber=81, createdTime=2024-04-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=19b2822489a0, moduleTitle=【期刊导读】HBsAg和HBsAb双阳性的慢乙肝患儿更易实现临床治愈, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=19b2822489a0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2198415, encodeId=6d132198415a6, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=a3f3e07054' target=_blank style='color:#2F92EE;'>#ETV#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【临床治愈集结号】免疫耐受期慢乙肝儿童采用聚乙二醇干扰素α联合ETV治疗获HBsAg清除, objectType=article, longId=819902, objectId=03ec819902f2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021554762_4754896.jpeg, objectUrl=/article/show_article.do?id=03ec819902f2, replyNumber=0, likeNumber=82, createdTime=2024-04-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=03ec819902f2, moduleTitle=【临床治愈集结号】免疫耐受期慢乙肝儿童采用聚乙二醇干扰素α联合ETV治疗获HBsAg清除, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=03ec819902f2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195713, encodeId=ff4b2195e1313, content=<a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=【期刊导读】首个荟萃分析：聚乙二醇干扰素α治疗慢性HBV感染患者获得HBsAg清除的预测因素, objectType=article, longId=818046, objectId=1507818046bd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=1507818046bd, replyNumber=0, likeNumber=59, createdTime=2024-03-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=1507818046bd, moduleTitle=【期刊导读】首个荟萃分析：聚乙二醇干扰素α治疗慢性HBV感染患者获得HBsAg清除的预测因素, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1507818046bd)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195033, encodeId=6e572195033d1, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=19332343e64' target=_blank style='color:#2F92EE;'>#乙肝疫苗#</a>, objectTitle=【期刊导读】HBsAg清除后接种乙肝疫苗有利于提高HBsAg血清学转换率及抗-HBs水平, objectType=article, longId=817866, objectId=711d81e866ea, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medic-563425_640.jpg, objectUrl=/article/show_article.do?id=711d81e866ea, replyNumber=0, likeNumber=70, createdTime=2024-03-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=711d81e866ea, moduleTitle=【期刊导读】HBsAg清除后接种乙肝疫苗有利于提高HBsAg血清学转换率及抗-HBs水平, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=711d81e866ea)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2194743, encodeId=8d0c2194e438c, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=【临床治愈集结号】初治HBeAg阴性慢乙肝患者HBsAg仍阳性时多次停药致病情反复，经多轮PEG IFNα治疗终获临床治愈, objectType=article, longId=817491, objectId=fe6681e491f3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/prescription-form-with-medical-stethoscope-9ZRKVHM.jpg, objectUrl=/article/show_article.do?id=fe6681e491f3, replyNumber=0, likeNumber=102, createdTime=2024-03-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fe6681e491f3, moduleTitle=【临床治愈集结号】初治HBeAg阴性慢乙肝患者HBsAg仍阳性时多次停药致病情反复，经多轮PEG IFNα治疗终获临床治愈, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fe6681e491f3)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 风湿免疫小助手

HBsAg

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #HBV# #聚乙二醇干扰素α-2b#

【期刊导读】慢性HBV感染女性产后采用基于聚乙二醇干扰素α-2b治疗48周的HBsAg清除率达50%

2024-09-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【愈见乙肝2024】合并脂肪肝的HBeAg阴性不确定期慢乙肝患者采用间歇治疗策略获HBsAg血清学转换

2024-09-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #聚乙二醇干扰素α# #慢乙肝#

【期刊导读】系统综述与网状荟萃分析：聚乙二醇干扰素α停药后的HBsAg清除率随观察时间递增

2024-09-05发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【愈见乙肝2024】长期核苷治疗的HBeAg阳性慢乙肝患者通过个体化间歇治疗策略获HBsAg血清学转换

2024-09-01发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肝细胞癌# #慢性乙肝# #HBsAg#

庄辉院士权威解读：慢性乙肝患者HBsAg清除后，HCC监测关键要点

2024-08-29发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #APASL 2024# #sPD-L1水平#

【期刊导读】HBsAg清除预测新指标：sPD-L1水平

2024-08-28发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #隐匿性HBV感染#

【期刊导读】HBV S区突变导致的HBsAg检测不到可能形成隐匿性HBV感染

2024-08-21发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肝癌# #HBsAg# #HBV#

【期刊导读】HBsAg高水平的HBV相关肝癌患者术后无复发生存期更短

2024-07-17发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #聚乙二醇干扰素α# #慢乙肝#

【临床治愈集结号】HBsAg高水平的HBeAg阳性慢乙肝母女经基于聚乙二醇干扰素α的治疗同获HBsAg血清学转换

2024-07-14发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肝癌# #HBsAg# #HBV感染#

【数据阅独】横断面调查：我国肝癌筛查目标人群的HBsAg阳性率为5.23%

2024-07-11发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #乙肝疫苗# #聚乙二醇干扰素α#

【期刊导读】经聚乙二醇干扰素α治疗获得HBsAg清除后联合乙肝疫苗可增强免疫应答，提高HBsAg血清学转换率

2024-07-06发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肝癌# #HBsAg# #抗病毒治疗# #慢乙肝#

【EASL2024速递】通过抗病毒治疗获得HBsAg清除的慢乙肝患者肝癌发生风险或更低

2024-06-06发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #干扰素α# #慢乙肝#

【EASL2024速递】聚血糖干扰素α能显著提高核苷停药慢乙肝患者HBsAg清除率

2024-05-30发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #HBV# #HBeAg# #慢乙肝#

【愈见乙肝2023】一对HBV DNA、HBsAg和HBeAg高水平的母女经个体化抗病毒治疗均获长期持久的临床治愈

2024-05-04发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【期刊导读】吴超教授团队：预测慢乙肝患者HBsAg血清学转换的新指标——基线HBsAb特异性B细胞

2024-04-29发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝# #HBsAb#

【期刊导读】HBsAg和HBsAb双阳性的慢乙肝患儿更易实现临床治愈

2024-04-25发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #聚乙二醇干扰素α# #ETV# #慢乙肝#

【临床治愈集结号】免疫耐受期慢乙肝儿童采用聚乙二醇干扰素α联合ETV治疗获HBsAg清除

2024-04-14发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#聚乙二醇干扰素α# #HBV# #HBsAg#

【期刊导读】首个荟萃分析：聚乙二醇干扰素α治疗慢性HBV感染患者获得HBsAg清除的预测因素

2024-03-27发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #乙肝疫苗#

【期刊导读】HBsAg清除后接种乙肝疫苗有利于提高HBsAg血清学转换率及抗-HBs水平

2024-03-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #HBsAg# #HBV#

【临床治愈集结号】初治HBeAg阴性慢乙肝患者HBsAg仍阳性时多次停药致病情反复，经多轮PEG IFNα治疗终获临床治愈

2024-03-22发表于上海

科室
- - 订阅+
  - 更多科室
工具
服务